You are here: Industry Insights > launch

News List

AstraZeneca launches 'Cancer Can Give' movement biospectrumasia
June 28, 2019
In celebration of National Cancer Survivors Day, AstraZeneca, a global, science-led biopharmaceutical company, on 27 June 2019, announced the launch of the ‘Cancer Can Give’ movement aimed at empowering cancer survivors to make a difference in society.
New vaping to quit smoking website launches biospectrumasia
June 13, 2019
The website was developed by the Ministry of Health and the Health Promotion Agency with input from a New Zealand expert advisory group.
PharmaTimes is excited to announce the launch of the Medical & Scientific Excellence Awards for the second year fiercepharma
April 25, 2019
Following on from the success of the inaugural PharmaTimes Medical & Scientific Excellence Awards, the 2019 competition is now open for entry – showcasing the very best professionals within medical affairs.
WHO launches new global influenza strategy biospectrumasia
March 13, 2019
WHO has released a Global Influenza Strategy for 2019-2030 aimed at protecting people in all countries from the threat of influenza.
OurCrowd launches $50M medtech fund biospectrumasia
March 07, 2019
The fund will be led by managing partners Dr. Morris Laster and Dr. Morry Blumenfeld and will be managed by a team of clinical experts with decades of experience in medical technologies and startup growth.
Philips launches new image-guided procedures in India biospectrumasia
March 06, 2019
Philips introduces Azurion with FlexArm in India to set a new standard for the future of image-guided procedures
Hill Holliday Health launches inside its Boston-based parent agency fiercepharma
March 05, 2019
Boston ad agency Hill Holliday has been doing pharma and healthcare work for years. But not many people seemed to know about it. So last week, the agency created a health-specific branded agency within itself with the launch of Hill Holliday Health.
Eli Lilly to launch authorised Humalog generic in the US at 50-percent lower list price firstwordpharma
March 04, 2019
Eli Lilly said Monday that it will launch an authorised generic version of Humalog (insulin lispro) in the US at a 50-percent lower list price than the original branded product as part of efforts to address the issue of patients' high out-of-pocket costs.
HiberCell launches with $60M+ to combat cancer relapse and metastasis fiercepharma
February 24, 2019
HiberCell, a new startup focused on preventing cancer metastasis and relapse, launched Thursday with research out of Mount Sinai and $60.75 million from the likes of ARCH Venture Partners, Hillhouse Capital and 6 Dimensions Capital.
Discounting hit J&J's Xarelto hard. Can a new launch turn things around? fiercepharma
January 23, 2019
Competition and discounting are understandably plaguing Johnson & Johnson's older drugs. But its cardiovascular blockbuster Xarelto is also on that list.

Previous page 1 2 3 Next page